LYNDA MCDONALD: Open Payments
NPI 1710472121 · AUGUSTA, GA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,660 in 84 payments from 17 companies in 2025. Trend: 2023 $225 · 2024 $2,742 · 2025 $1,660
Food & beverage: $1,660
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 17 | $271 |
| Janssen Biotech, Inc. | 8 | $219 |
| PFIZER INC. | 9 | $206 |
| QOL Medical, LLC | 11 | $183 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 13 | $166 |
| Takeda Pharmaceuticals U.S.A., Inc. | 5 | $123 |
| Madrigal Pharmaceuticals | 4 | $100 |
| GENZYME CORPORATION | 3 | $72 |
| Acera Surgical, Inc. | 3 | $64 |
| Regeneron Healthcare Solutions, Inc. | 2 | $62 |
Products named: TREMFYA, VELSIPITY, Sucraid, XIFAXAN, DUPIXENT, REZDIFFRA, RINVOQ, VIBERZI.
Industry payments across GA — which companies pay providers there.
